About binding proteins
"Binding Proteins are next-generation fermented IgG fragments designed for precision and gut resilience."
Introduction to Binding Proteins
Being able to safeguard your gut is critical to staying healthy: Like infants are protected by IgGs in mother’s milk, Binding Proteins have the potential to support the large populations world wide from unhealthy metabolites or enterotoxins.
Unlike broad-spectrum immunity ingredients, they selectively bind to unhelathy metabolites (toxins), supporting gut balance without disrupting the microbiome. With a vegan-friendly profile and proven efficacy at low daily intake, Binding Proteins offer a science proven Mode of Action to immune and digestive health.


Binding Proteins Origin
It was discovered in 1993 that immunoglobulins (IgG) from camelids (camels, alpacas etc.) have a simple structure, and a binding domain comprising a single polypeptide chain, making it a small stable protein with a targeted binding activity.

Precision Fermentation
Binding Proteins are manufactured using established food industry best practices, including established (GRAS) microbial expression methods, adherence to Good Manufacturing Practices (GMP), and Hazard Analysis and Critical Control Points (HACCP)Protocols.

Mode of Action
Each unique Binding Protein specifically binds to selected unhealthy metabolites (toxins), facilitating their safe and gentle passage through the GI-tract. While antibiotics eliminate bacteria in the gut, Binding Proteins have no kill effect, and do not cross the gut epithelial barrier or activate the immune system, and have a fast onset of action with effects observable shortly after ingestion.
"Each Binding Protein specifically binds to selected microbial toxins, undesired metabolites, or microbes facilitating their safe and gentle passage through the gastrointestinal tract."


Related Articles

Gut Defense: How IgG Binding Protein LT Supports Barrier Integrity Over Conventional Immunoglobulins
In the last decade, gut health has rapidly gained importance among consumers and researchers, driven by increased awareness and advancing scientific evidence. Central to this interest is mounting research showing that a balanced gut microbiota supports overall health, while an unbalanced gut microbiota is linked to metabolic, immune, and gastrointestinal (GI) disorders

Introducing Giga Binding Units (gBU): A Functional Measurement Standard for Immunoglobulin Ingredients
Walk into any supplement retailer or browse online marketplaces for immunoglobulin products, particularly IgG and IgY, and you will notice something striking. Products making similar digestive and immune health claims recommend vastly different daily servings; one product suggests 200mg, another suggests 2,500mg, over 12 times higher. This variation makes it difficult for consumers to evaluate product value, for formulators to select ingredients and establish serving sizes, and for researchers to compare outcomes across studies. For a category valued at more than $5 billion and growing at a CAGR of more than 7%, this is a challenge worth solving.

A New Gut Sense: How Microbial Cues May Quickly Shape Appetite
Imagine you’re about to eat, and then your appetite simply fades. What might have happened? One possibility involves microorganisms living in the gut. The intestinal microbiota can engage gut–brain neural circuits, but the molecular mechanisms mediating these interactions remain incompletely understood.